Showing results (201-210 of 538) with videos related to

Sort By:
Pageof 54
Annals of the Rheumatic Diseases|July 31, 2013
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trialRaphaèle Seror, Gabriel Baron, Eric Hachulla, et al.
Nature Reviews. Disease Primers|July 8, 2016
Sjögren syndromePilar Brito-Zerón, Chiara Baldini, Hendrika Bootsma, et al.
RMD Open|February 14, 2018
Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational studyRieke Alten, Xavier Mariette, Hanns-Martin Lorenz, et al.
Arthritis Care & Research|April 15, 2010
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity IndexRaphaèle Seror, Xavier Mariette, Simon Bowman, et al.
Arthritis Research & Therapy|May 28, 2009
Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathiesCorinne Miceli-Richard, Nicolas Gestermann, Corinne Amiel, et al.
Annals of the Rheumatic Diseases|July 18, 2015
Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndromeCorinne Miceli-Richard, Shu-Fang Wang-Renault, Saida Boudaoud, et al.
Joint Bone Spine|January 4, 2017
The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION studyXavier Mariette, Rieke Alten, Hubert G Nüßlein, et al.
Rheumatology (Oxford, England)|May 16, 2021
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abataceptClaire Rempenault, Cédric Lukas, Bernard Combe, et al.
Clinical and Experimental Rheumatology|February 21, 2012
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registryArsene Mekinian, Philippe Ravaud, Claire Larroche, et al.
ACR Open Rheumatology|July 1, 2021
Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass IndexVivian P Bykerk, Andrew Blauvelt, Jeffrey R Curtis, et al.
Pageof 54